12^th Annual Conference on Stem Cell and Regenerative Medicine June 04-06, 2018 Prague, Czech Republic

Bob Hariri is a Co-founder and Vice Chairman, Human Longevity, Inc. Former Founder and Chairman, Celgene Cellular Therapeutics surgeon, biomedical scientist and highly successful serial entrepreneur in two technology sectors: biomedicine and aerospace. chairman and chief scientific officer of Celgene Cellular Therapeutics, one of the world’s largest human cellular therapeutics companies, Dr. Hariri has pioneered the use of stem cells to treat a range of life threatening diseases and has made transformative contributions in the field of tissue engineering

Discovery of pluripotent stem cells,Tissue Engineering,Biomedicine and Aerospace.

Dr. Todd Malan is considered one of the true pioneers of fat derived stem cell therapies in the USA. In October of 2009, Dr. Malan was the first U.S. physician to utilize adipose or fat derived stem cells for soft tissue reconstruction. He has described his techniques and experience as an author in two medical textbooks as well as having presented at dozens of stem cell conferences worldwide. Dr. Malan has been pivotal in developing safe protocols for stem cell harvesting and deployment for regenerative medicine and has trained hundreds of physicians worldwide in the safe and effective use of adipose derived stem cells. Dr. Malan began to seek out ways to utilize adipose stem cells for regenerative applications after a close family member was diagnosed with multiple sclerosis (MS). Dr. Malan now divides his practice time into cosmetic stem cell procedures and regenerative medicine research for patients with chronic disease and degenerative disorders.

Regenerative Medicine , Stem Cells ,

Dr.DESIREE COX, MD, PhD – Rhodes Scholar, educated at McGill University, Oxford University and Cambridge University. She has rightly earned her place as a Thought-Leader in healthcare and education and is highly respected health consultant internationally. Her focus is on health innovation, the regulatory aspects of the global stem cell and regenerative medicine, and medical tourism. Dr. Cox has 20+ years in the healthcare field with an impressive career and a rare and unique range of skills and capacities gained from a career that has spanned clinical medicine, academia, research and development, regulatory sciences, health and social enterprise. She has worked in the UK, US, Canada and The Bahamas. Her experience in healthcare consulting includes consulting for biotech companies and major pharmaceutical companies including Amgen, GSK, and Novartis on pipeline therapeutic products and medical devices. Since 2015 she has been spearheading health innovation in The Bahamas and the development of the stem cell and regenerative industry in The Bahamas. She is the Founder and CEO of The HEALinc Health Innovation Incubator (www.thehealinc.com). She is also a Singularity University Social Impact Fellow and Ambassador/License-holder of the recently launched SingularityU Nassau Chapter fostering the use of accelerating/exponential technologies

Stem cell and regenerative medicine, bioethics, exponential technologies, creativity, and 'future-health' education and talent development

Walter Bini has completed his Diploma at Westminster School, Simsbury Conn. USA and Post-graduate degree at Universidad de Zaragoza, Facultad de Medicina, Zaragoza-Spain. In 2014, he was the Middle East Chairman of ISLASS. He was Head of Neurosurgery at Sheikh Khalifa General Hospital, UAQ-UAE from 2014- 2016. Currently, he is Consultant Neurosurgeon in Orthopedic department, spine section of Lanzo Hospital COF, Lanzo d’Intelvi in Italy and also Visiting Consultant Neurosurgeon in Orthopedic department at Healthpoint Hospital, UAE.

Neurology,Neurosurgery,Orthopaedics.

Henry M. Sobell completed his studies at Brooklyn Technical High School (1948-1952), Columbia College (1952-1956), and the University of Virginia School of Medicine (1956-1960). Instead of practicing clinical medicine, he then went to the Massachusetts Institute of Technology (MIT) to join Professor Alexander Rich in the Department of Biology (1960-1965), where, as a Helen Hay Whitney Postdoctoral Fellow, he learned the technique of single crystal X-ray analysis. He then joined the Chemistry Department at the University of Rochester, having been subsequently jointly appointed to both the Chemistry and Molecular Biophysics departments (the latter at the University of Rochester School of Medicine and Dentistry), becoming a full tenured Professor in both departments (1965-1993). He is now retired and living in the Adirondacks in New York, USA.

Structural Biology, Gene Therapy

Helen completed her PhD in 1997 at University College London. Her career then consisted of postdoctoral studies at the University of Bath, an MRC fellowship, followed by a tenured position at the University of Ulster. She is currently a senior lecturer at the University of Glasgow with expertise in stem cell signal transduction specialising in leukaemia research. She is also Associate Dean of Post-graduate Research within the College of Medical, Veterinary and Life Sciences at the University of Glasgow. She has published more than 25 papers in reputed journals and regularly reviews papers, grants and serves on editorial boards. She is active in promoting public understanding of stem cells and Bioethics surrounding the use of stem cells and animal models in science.

Stem Cell Biology, Cancer Science ,Translational Medicine

Prof. B. Marchetti is a member of > 30 national and international neuroscientific societies, published > 100 full papers in peer reviewed Journals, > 100 full length Chapters in Books; presented > 200 Abstracts at both National and International Meetings, acts as Invited Speaker and Conference Chairman in National and International Meetings, organized uccessful Workshops in the field, and acts as Guess Editor of Special Issues. Prof Marchetti’s research projects are sponsorized by Italian Ministry of Health, Italian Ministry of University Research, the Italian Multiple Sclerosis Foundation and European Research Council (ERC) Projects; the Canadian Institutes of Health Research and the Fonds de recherche du Québec en santé (FRQS); Fondazione con il Sud - Bando Capitale Umano ad Alta Qualificazione 2015 grant; and Network of Centres of Excellence in Neurodegeneration (CoEN) 2017, Pathfinder III project grant

Prof. Marchetti’s fields of interests include hormones, neuroinflammation, neurodegeneration and neuroprotection, glia-neuron interactions in neurodegenerative diseases including, Multiple sclerosis, Parkinson’s (PD) and Huntington’s diseases (HD). Research fields of the Team have expanded from the study of the Glucocorticoid receptors (GRs), stress, inflammatory mediators in programming the predispostion to disease entities (including endocrine and neurological disorders) such as experimental allergic encephalomyelitis (a rodent model of Multiple Sclerosis), the MPTP and 6-OHDA rodent models of PD in transgenic GR knock out mice, expressing from early embryonic life a GR antisense RNA. The critical role of estrogens in neuroprotection and neuroinflammation has been also highlighted studying the effect of P450 aromatase KO mice in DA neuronal systems and vulnerability to PD, in particular the role of gender and estrogens in astrocyte and microglia response to PD neurotoxins, together with the anti-inflammatory mechanisms of estrogen in neuroprotection, and the associated therapeutical interventions. The class of non-steroidal antiflammatory drugs (NSAIDs), as the nitric-oxide releasing NSAIDs (such as NO-Flurbiprofen) have been characterized for their ability to exert a significant degree of neuroprotection of the nigrostriatal DA neurons in rodent models of the disease. More recent BM research activities focus on the study of adult neurogenesis and neurodegeneration/neuroprotection in PD, on intercellular communications between glial cells, neurons and stem/neuroprogenitor cells (NSCs), highlighting the role of inflammation in the plasticity of subventricular zone (SVZ)-NSCs and their therapeutical implications for nigrostriatal DA neurorestoration in rodent models of PD, in setting in vitro and in vivo models to elucidate novel signaling pathways involved in neuronal cell

Dr Mohammad Hasan Sheikhha Is one of finest pioneer in stem cell industry he is associative director for Yazd Clinical & Research Center for Infertility Yazd University of Medical Sciences Mohammad Hasan Sheikhha has completed his PhD in 2002 from Manchester University, UK. He is the president of International Campus, Shahid Sadoughi University of Medical Scienecs, Yazd, Iran. He is workind as professor of medical genetics and has published more than 100 papers in reputed journals and has been serving as an editorial board member of International Journal of Reproductive Biomedicine.

Stemcells,Molecular Genetics,

Dr. Choudhery earned a BS (Hons) degree from the University of Punjab in 2007. He completed his Doctorate from National Center of excellence in Molecular Biology (CEMB) in 2012. He completed a part of his research work in Professor David Harris’s Laboratory at College of Medicine, Department of Immunology, The University of Arizona, Tucson, USA. Dr. Choudhery also worked as Post-doctorate Fellow at the College of Medicine, Department of Immunology, The University of Arizona, Tucson, USA. In 2012 he joined the faculty at the King Edward Medical University as an Assistant Professor. Dr. Choudhery’s research interests include clinical applications of stem cells, caloric restriction, tissue engineering, stem cell transplantation and gene therapy. Further he has a great interest in developing cell-free stem cell based therapies. He has published several research articles in peer reviewed international journals. Currently he is serving as a reviewer and editorial board member of more than 15 international Journals.

Stem cell based regenerative therapies, Tissue Engineering and Regenerative Medicine, stem cell transplantation and gene therapy, Cell-free stem cell based therapies

Raised in Rudrapur, Dr. Himanshu Bansal completed his medical school residency and post graduation from King George Medical College in Lucknow, U.P. During his post graduation, he actively pursued work focused on spinal cord injury and after having subsequently presented his work at variety of forums, he decided to enrich himself in Hip and Knee replacement at Aarhus University Hospital at Denmark, Hip replacement unit of Guy’s Hospital of Kings College at London and Orthopaedic Traumatology unit of Wurzburg university hospital at Germany & microsurgery at Osaka city university Japan. Because of his interest for Striving excellence in management of spinal cord injury decided to work exclusively for spinally injured, he undertook various visits at: Miami Project to Cure Paralysis (Miami University) USA. Reeve-Irvine Research Center, California USA. Queen Elizabeth Spinal Trauma Centre, Glasgow, Scotland. Neuroscience Center-Rutgers University USA. Egaz Monis hospital, lisbon , Portugal. European spinal cord research institute, Brescia Italy.

Stem cell Research , micro surgery ,Traumataology

Dr. Mahajan completed his post-graduation in General Surgery from Marathwada University, Maharashtra and went on to pursue Diploma in Urology at the University of Vienna, Austria. In a career changing move, after three decades of being a successful general and uro-surgeon, he started his brainchild-StemRx Bioscience Solutions Pvt. Ltd. in the year 2011. This was to focus on in-depth research in the field of Regenerative Medicine and Cell Based Therapy which he believes is the solution to address the limitations of conventional therapeutic modalities. To this effect, he underwent and continues to undergo intensive training in the field at both national and international levels. He has devised personalized treatment protocols in cell based therapy for more than 75 health conditions. Dr. Mahajan is a Life member and Joint Secretary of The Stem Cell Society of India as well as Vice President of Anti-Aging Foundation, Delhi and Scientific National Advisor, Indian Stem Cell Study Group. He has been appointed as Hon. Associate Professor of Regenerative Medicine and Cell Based Therapy at Dr. R N Cooper Hospital, Mumbai and Faculty for MD Transfusion Medicine at KEM Hospital, Mumbai. Dr. Mahajan’s academic collaborations include those with the Maharashtra University of Health Sciences and ITM University (Raipur). Among his international associations, a clinical trial in collaboration with the Ohio State University, USA on Cell Based Therapy for Avascular Necrosis is noteworthy, wherein Dr. Mahajan is a Principal Investigator. His recent international ventures include extension of StemRx facilities in Africa and collaboration with an organization in Japan to launch NK cell (cancer immunotherapy) technology for solid tumours in India. He has published an international patent for treatment of Avascular Necrosis using Regenerative Medicine approach and Indian patents for Avascular Necrosis, Ankylosing Spondylitis, Ischemic-tolerance Mesenchymal Stem Cell treatment/technology and isolation of dental pulp stem cells. He has many paper publications to his credit. His drive to achieve tangible outcomes in research and therapy has earned him recognition and several awards in the field of healthcare—Paris Appreciation Award and National Award for Excellence in Healthcare (Clinical Research category) to name a few. His vision is to achieve excellence in cell based therapy at a global level, while also ensuring that the technology is accessible to the masses. In his own words—“‘You carry your own repairing kits within yourself’. Soon, I believe that there will be a day when treatments will comprise of Cells and not Pills!”

Stem Cells, Regenerative Medicine , urology

Dr. Chandan Bora completed his Masters degree from SGB Amravati University (India) and Doctorate degree from Rani Durgavati University (India). His research areas are Immunology; Microbiology and Molecular Biology. During doctorate degree he completed one major research project titled “Investigation on ecological; clinical; and genotypic properties of non cholera vibrios” He has presented research papers in many national and International conferences. He has also published national and international research papers; reviews and book chapters. He is the editorial board member of journal BOAJ Cancer Research and Therapy and active advisory board member of BIO ACCENT GROUP LLC. He has several years of experience in autologous cellular therapies especially Dendritic cell therapy; Activated T cell therapy and tumor infiltrating lymphocyte therapy. He has actively participated in clinical trials on dendritic cells in solid tumors. He has experience in diagnostic industry especially related to immunocompromized diseases like AIDS, Cancer etc.

Immuno therpy,Cancer,cell Therapy, Mesenchymal Stem cells

Jonathan Schwartz has over 37 years doing international business consulting for emerging medical technologies and has been focused on stem cell technologies and regenerative medicine for the past nine years. He currently is the President of Xanadu Stem Cell Institute and Research Group and has done business consulting for many companies globally, including, LCCELL, Mystem, Bioquark, Diponed Biointelligence, Weber Medical, Cell Innovations, Telomere Biosciences, WeHealPlus, Fit For Life, Coloplast, Smith & Nephew, GLO PRP, many others. He has previously worked in Management and Executive capacities with Spacelabs Medical, GE Healthcare, Intellicell Biosciences. He has degrees from Queens College and NYU Medical School.

His research interests are stem cells, regenerative medicine, cell therapy. clinical trails.

Lucie Bacakova has graduated from the Faculty of General Medicine, Charles University, Prague, Czechoslovakia in 1984. She has completed her PhD from the Czechoslovak Academy of Sciences and became Associate Professor at the 2nd Medical Faculty, Charles University. She is the Head of the Department of Biomaterials and Tissue Engineering, Institute of Physiology, Academy of Sciences of the Czech Republic. She is a Specialist for studies on cell-material interaction and vascular, bone and skin tissue engineering. She has published more than 150 papers in reputed journals

Biomaterials, Tissue Engineering etc

Michele Zocchi graduated in Turin in 1976. He lived for over ten years abroad, first in the United States and then in France to obtain specialties in maxillofacial surgery and in plastic and aesthetic surgery. He has worked and works as an in-house doctor and as a researcher in the most prestigious institutions worldwide, mainly in Brazil, Spain, France and the United States. Today the prof. Zocchi is recognized among the pioneers and among the most authoritative professional figures in the world in the field of body contouring surgery, of the physio-pathology of adipose tissue and of tissue regeneration. Since 1988, with his return to Italy, he has focused his professional interest especially in the field of lipoplasty and liposculpture, providing a fundamental contribution to the research and development of new methodologies and new surgical protocols, inventing and refining the related instruments . Among others, ultrasound lipoplasty , bicompartmental lipostructuring of the breast and the production of adult mesenchymal stem cells from adipose tissue aimed at tissue regeneration stand out . In his career, prof. Zocchi has carried out more than ten thousand surgical operations, while at the same time conducting an intensive congress and teaching activity in university institutes and educational programs. He has been speaker and guest of honor in over 400 international congresses in more than 40 countries. He is the author of over 150 books, monographs and publications on the most prestigious international journals in the sector. He is an effective or honorary member of more than 20 international surgical societies and professional associations . He holds the position of scientific director, responsible coordinator and teacher in charge of the permanent training program (PFP) of the Italian Society of Plastic, Reconstructive and Aesthetic Surgery . He is National Delegate for Italy of Espras (European Confederation of National Plastic Surgery Societies). He is fluent in Italian, English, French, Spanish and Portuguese.

Regenerative Medicine , Cord blood cells, Lipoplasty,tissue regeneration

Pedro Morouço is a very enthusiastic and provoking early-career researcher. Currently, is the Head of R&D Biofabrication Group at the Centre for Rapid and Sustainable Product Development – Polytechnic Institute of Leiria, Portugal. He is the Principal Investigator of “2bio4cartilage – Integrated intervention program for prevention and treatment of cartilage lesions; POCI-01-0145-FEDER-023423 co-financed COMPETE2020 under PT2020 programme, and supported by FEDER”, and his research activity focuses, mostly, on products and processes engineering, aiming to bringing the gap between the lab and in vivo applications. In the last years, he has been invited to collaborate in several national and international projects, providing a significant income for the Biofabrication Group (currently has 8 grant-holders). Despite his young age, he has co-edited books, authored and co-authored more than 200 scientific works, is member of the scientific committees in various conferences, member of the Advisory Board on TERM for Cambridge Scholars Publishing, and editorial member and reviewer of various journals. His work has been presented as a Keynote speaker in Stem Cell and Regenerative Medicine 2016 (Manchester, UK), Tissue Engineering and Regenerative Medicine 2016 (Berlin) and 2017 (Barcelona), and International Conference on Advances in Skin, Wound Care and Tissue Science 2017 (Frankfurt). Above all, Pedro is a humble researcher that understand the values of working as a team. Natural leader to reinforce the strengths and bridge weaknesses of his R&D group, developing new ideas and thinking outside the box. Finally, Pedro is aware of the role of science for society awareness. Thus, he developed skills to be able to reach wider audiences (2 awards in the National Science Communications Contests and representative of Portugal in an international event, Winner of The Publishing Method competition by the American Journal Experts, 2017, was distinguished with the New Investigator Award 2014 and Hans Gros Emerging Researcher Award 2017 from ISBS, Prestigious Award 2017 by the Leiria City-hall and named one of the Personalities for 2017 by the regional press).

Cartilage Regeneration and 4d Bio Printing, Biomaterials

Professor Frank Staal’s research is centred around the differentiation of blood-forming stem cells (hematopoietic stem cells, HSCs) to the major disease fighting white blood cells The research of Frank J.T. Staal focuses on molecular regulation of immature T lymphocyte development and hematopoietic stem cell biology. Besides basic aspects of transcriptional regulation and cell signalling in mouse and human, this knowledge is applied to diagnosis and gene therapy applications of primary human immunodeficiencies as well as to abnormal lymphoid development in acute lymphoblastic leukemias. Translational research leading to novel diagnostic and therapeutic tools is an integral part of his research activities.

Retroviral transduction ,Gene therapy,Stem cell assays, FTOC, Reporter gene assays, Immunology assays, T cell clones; Molecular biological techniques, Protein chemistry, Kinase assays

Director of Moscow Research Institute of Eye Microsurgery and father of the modern Radial Keratotomy for the surgical correction of myopia, Massimo Lombardi is the first European ophthalmologist who attends in Moscow the courses on training in the most recent techniques for the microsurgery of the eye. 1987: He is the only private in the world who comes to an arrangement with the Moscow Institute of Eye Microsurgery, through the Soviet Ministry of Health. This agreement allows him the possibility to try new ideas in the field of ophthalmological research with the help of several équipes. He obtains the Specialization in Ophthalmology at the University of Rome “La Sapienza. He performs for the first time in the world the operation of “Lasik” on pig eyes. He holds in Atlanta a specialization course in refractive surgery to ophthalmologists from many different countries.

Micro Surgery,Mini Asymmetric Selective Radial Keratotom,Stem Cells

Ivana Haunerova is a Quality Assessor for biotech and advanced therapy medicinal products in the State Institute for Drug Control in the Czech Republic. She has completed her graduation in Biochemistry at the Institute of Chemical Technology, Prague. Since 2009, she is a Member of the Committee for Advanced Therapies at EMA

Quality assessment of biological and biotechnological drug products including advanced therapy medicinal products and tissue and cells Regulatory affairs of advanced therapy medicinal products

Dr. Amgad M. Rabie, Professor & Researcher of Pharmaceutical Organic (Medicinal) Chemistry & Drug Design/Discovery, Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt. He is the editor-in-chief & the chairman of the peer-reviewing committee of the famous & reputable journal in pharmaceutical sciences & researches worldwide, International Journal of Pharma Sciences and Scientific Research (IJPSR), USA, Canada, Europe, Asia, Egypt, Australia, and Brazil.His major role is to help the American Chemical Society (ACS; which is the most famous & best ranked international chemistry organization) to improve people’s lives through the transforming power of chemistry. He is also a editorial board director & chairman of the multidisciplinary and internationally famous & comprehensive journal in all pharmaceutical & medicinal sciences worldwide, Journal of Pharmaceutical and Medicinal Research

Biotechnology, Drug Discovery

Simon Checkley is Managing Director at The Regenerative Clinic at United Kingdom. He did B.SC Biology in Liverpool Moorse University and also done Masters in University of Brighton and completed his Executive Leadership Program at Harvard Business School .He acted as Strategic Managing Director at Stryker Trauma Europe.

Business Management, Geographies in sales, Marketing and General Management

Dr Janice Fisher is a medical doctor trained at the University of the West Indies, Mona, Jamaica. Spanning across the globe, Dr. Fisher has done Nutrition fellowship training in the United States, Ecuador, Mexico and Germany. She is also an active member of the American Academy of Anti- Aging Medicine. She has received a Merit of Special Service for missionary work and Order of Excellence from the World Association of Natural Medicine Practitioners. Beyond this, Dr. Fisher enjoys time with her husband and two children in their Kingston home.

Regeneration Medicine and Anti Aging Medicine

Dear Dr John Ioannis Grigoriadis is Account Manager at Bennett Pharmaceuticals and Biogenea Pharmaceuticals Ltd, Greece. He completed his education at Technical University of Thessaloniki and Done pharmacy doctorate and he is account manager for Med one Pharmaceuticals. In span of 38 years he published nearly 270 Publications

Pharmaceuticals and Marketing research, Stem Cell, Gastroenterology, Healthcare

Dr. Sandeep Shrivastava practices at Medanta Super Speciality Hospital and Specializes in Cardiac Surgery. Prior to joining Medanta as Principal Consultant- Cardiac Surgeon, Dr Shrivastava worked as Senior Consultant Cardiothoracic Surgeon & Head CVTS at Nawaloka Hospital PLC, Colombo from 2007- 2010. Dr Shrivastava has to his credit over 7000 cardiac surgeries, including adult & pediatric cases for heart valve repairs, CABG on beating heart, and a large number of arterial revascularizations including LIMA – RIMA Y grafting, LIMA – Radial "Y" grafting & Radial – Radial "Y" grafting. He led the team that conducted the first double lung transplantation in Sri Lanka, thus creating history.

Beating Heart Coronary Artery Bypass Surgery Total Arterial Revascularization,Cardiology